ATH 33.3% 0.4¢ alterity therapeutics limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-55

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,153 Posts.
    lightbulb Created with Sketch. 109
    Hi Skint,

    Theres a few small journal articles (neurology) out there if you type in ATH434 news, but not as much as one could hope and would want, but than also the recent results were on very small group, and results were also, as Dr Stamler stated, was aimed at the FDA, and not a sell the news result.

    Once the market hopefully starts to improve, and the recent downturn gitters clears the minds, buyers will return, or change their mind and hold their parcel.

    As stated previously, I'm not going anywhere.

    Obviously theres interest, as we opened with a fair amount at 3c, sneaky 2.5c bid, cleared the 3c and now have 14mill shares waiting to be bought at 3c.

    Futures continue to improve ATM, so hopefully so does the ATHE. Little concerned with upcoming seasonal market downturn through Sept-Oct. Hopefully the recent correction will be enough to keep the market steady.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
0.001(33.3%)
Mkt cap ! $21.28M
Open High Low Value Volume
0.3¢ 0.4¢ 0.3¢ $6.645K 2.055M

Buyers (Bids)

No. Vol. Price($)
44 24995682 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 131374606 34
View Market Depth
Last trade - 16.10pm 14/10/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.